SCHEMBL31282986

SCHEMBL31282986

CN(C)/C=C1\COC2(CCN(C(=O)OC(C)(C)C)CC2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ AVPR1A P37288 3/20 0.38
▸ USP30 Q70CQ3 1/20 0.35
▸ DDB1 Q16531 2/20 0.34
▸ CRBN Q96SW2 2/20 0.34
▸ RECQL P46063 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TGM2 P21980 1/20 0.33
▸ ACACB O00763 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317081 0.86 USP30 (0.35) USP2SMN1; SMN2AVPR1AUSP30DDB1
SCHEMBL21843465 0.78 USP2 (0.49) USP2SMN1; SMN2AVPR1ADDB1CRBN
SCHEMBL21273181 0.76 USP2 (0.40) USP2SMN1; SMN2USP30KDM4EMAPT
SCHEMBL21273179 0.76 USP2 (0.40) USP2SMN1; SMN2USP30KDM4EMAPT
SCHEMBL21273182 0.76 USP2 (0.40) USP2SMN1; SMN2USP30KDM4EMAPT
SCHEMBL1621681 0.76 USP2 (0.43) USP2SMN1; SMN2DDB1CRBNKDM4E
SCHEMBL24417745 0.76 USP2 (0.43) USP2SMN1; SMN2DDB1CRBNKDM4E
SCHEMBL22999578 0.75 USP2 (0.38) USP2SMN1; SMN2DDB1CRBNKDM4E
SCHEMBL1528547 0.72 USP2 (0.38) USP2SMN1; SMN2DDB1CRBNKDM4E
SCHEMBL1528546 0.72 USP2 (0.38) USP2SMN1; SMN2DDB1CRBNKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705293-A1 SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2026-03-11 — — EP disclosed
WO-2024229317-A1 SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-11-07 — — WO disclosed
Send feedback